Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT07243639

Efficacy and Safety of Etrasimod in Elderly Patients With Ulcerative Colitis

Conditions: Ulcerative Colitis (Disorder)

Sex: All

Healthy volunteers: No

Phase: NA

Enrollment: 30

Sponsor: Showa Inan General Hospital

Location: Showa Inan General Hospital Komagane Nagano

Summary

Eligible patients will be identified in regular clinical practice. After providing thorough explanation and obtaining voluntary written informed consent, the clinical course, adverse events, endoscopic findings, and histopathological changes in biopsy specimens after Etrasimod administration will be prospectively collected and analyzed.

Eligibility Criteria

Inclusion Criteria: * Patients with active ulcerative colitis Exclusion Criteria: * the presence of acute or chronic renal failure, chronic heart disease, pulmonary infection, liver cirrhosis, colorectal cancer, autoimmune disease, and infectious disease

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07243639). StuddyBuddy aggregates publicly available trial information.